View in EDS

Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.

Saved in:
Bibliographic Details
Title: Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
Authors: Duncan JL; Department of Ophthalmology, University of California, San Francisco, San Francisco.
Source: NEJM evidence [NEJM Evid] 2025 Aug; Vol. 4 (8), pp. EVIDe2500127. Date of Electronic Publication: 2025 Jul 22.
Publication Type: Editorial
Journal Info: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40693849
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Duncan+JL%22">Duncan JL</searchLink>; Department of Ophthalmology, University of California, San Francisco, San Francisco.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918317485806676%22">NEJM evidence</searchLink> [NEJM Evid] 2025 Aug; Vol. 4 (8), pp. EVIDe2500127. <i>Date of Electronic Publication: </i>2025 Jul 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22NEJM+Group%2C+a+division+of+the+Massachusetts+Medical+Society%22">NEJM Group, a division of the Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918317485806676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2766-5526 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227665526%22">27665526 </searchLink><i>NLM ISO Abbreviation: </i>NEJM Evid <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40693849
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1056/EVIDe2500127
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: EVIDe2500127
    Titles:
      – TitleFull: Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Duncan JL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2766-5526
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: NEJM evidence
              Type: main
ResultId 1